Phillip Taboada/X
Aug 26, 2025, 09:56
Phillip Taboada: TXA Shows No Added Benefit in Aquablation
Phillip Taboada, MS4 at UT Southwestern Medical Center and urology applicant, posted on X:
”New work in New work in Canadian J Urology.
Limited TUR during Aquablation provides adequate hemostasis. TXA offered no clear benefit in reducing hematuria or transfusions.
Thanks UT Southwestern Urology for the support!”
Read the full article here.
Title: Tranexamic acid and hematuria outcomes following aquablation for benign prostatic hyperplasia
Authors: Phillip Taboada, Rohit R. Badia, Dhillon Advano, Andrew Murphy, Christina Sze, Ryan J. Mauck, Jennifer Tse, Jeffrey Gahan, Claus G. Roehrborn, Ramy Goueli
Stay updated on the latest scientific advancements with Hemostasis Today.
-
Apr 16, 2026, 18:27Are We Underestimating VTE After PanNET Surgery? – RPTH Journal
-
Apr 16, 2026, 16:10Hamid Noori: Etiological Classification of Anemia Understanding the Root Cause
-
Apr 16, 2026, 15:29Sebastian Klapa: Key Findings On Mortality And Cardiovascular Risk In ANCA-Associated Vasculitis
-
Apr 16, 2026, 15:23Ifeanyichukwu Ifechidere: Argatroban – Its ‘Rescue Mission’ in Heparin-Induced Thrombocytopenia
-
Apr 16, 2026, 14:58Early Diagnosis Can Change Everything in Hemophilia Care – WFH
-
Apr 16, 2026, 14:05Saleh Shamse Basha: When Platelet Counts Mislead, The PLT-F Becomes Critical
-
Apr 16, 2026, 13:44Maha Othman: Celebrating National Medical Laboratory Week in Canada
-
Apr 16, 2026, 13:42Megan Adediran: How Much of What You Know About Hemophilia Is True?
-
Apr 16, 2026, 13:35Priya Singh: How to Write the Discussion of a Research Paper